Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
General Internal Medicine
•
Neurology
When do you consider switching a generic formulation antiseizure medication to the brand formulation?
Related Questions
What markers on EEG can help predict/detect postoperative or ICU-related delirium?
What work-up and treatment do you recommend for exertional headaches?
Do you typically give GI prophylaxis when providing patients with steroid taper for status migrainosus?
When do you need to keep patients on anti-seizure medications when they had an acute symptomatic seizure in the setting of eclampsia, particularly if MgSO4 was given and there was no seizure recurrence?
What are your preferred second-line medications for trigeminal neuralgia?
Do you use alcohol to trigger seizures in patients you suspect to have JME to confirm diagnosis?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
How do you approach questions regarding clearance for elective surgery in patients with epilepsy?
What is the role for inpatient limited-montage EEG recording?
When do you target the thalamus for SEEG exploration or neuromodulation in patients with drug-resistant epilepsy?
